ABSTRACT
The denim textile industry represents an important productive sector. It generates wastewater with low biodegradability due to the presence of persistent pollutants, which can produce toxic and carcinogenic compounds; therefore, wastewater treatment reduces risks to aquatic life and public health. This paper presents a review of 172 papers regarding textile industry wastewater treatment for the removal of contaminants, especially indigo dyes used in the denim industry, in the context of green technologies. The physicochemical characteristics of textile wastewater, its environmental and health impacts, and the permissible limit regulations in different countries were reviewed. Biological, physicochemical and advanced oxidation processes for the removal of indigo dyes were reviewed. The goal of this study was to analyze the characteristics of green technologies; however, the research does not clearly demonstrate an effect on energy consumption savings, carbon footprint decreases, and/or waste generation. Advanced oxidation processes showed the highest color removal efficiency (95 and 97% in synthetic or real wastewater, respectively). Photocatalysis and Fenton reactions were the most efficient processes. None of the revised works presented results regarding upscaling for industrial application, and the results should be discussed in terms of the guidelines and maximum permissible limits established by international legislation. New technologies need to be developed and evaluated in a sustainable context with real wastewater.
Subject(s)
Drug Hypersensitivity/diagnosis , Electronic Health Records , Food Hypersensitivity/diagnosis , Hospital Information Systems , Reminder Systems , Critical Pathways , Cross-Sectional Studies , Drug Hypersensitivity/epidemiology , Food Hypersensitivity/epidemiology , Humans , Prevalence , Risk Factors , Spain/epidemiologyABSTRACT
SNOMED CT es una terminología clínica comprensiva y detallda, en español, que puede utilizar para repesentar información puede utlizar para representar información clínica relevante de forma constante. El Hospital Universitario de Fuenlabrada ha adoptado SNOMED CT en sus sitemas de información mediante dos métodos. Se han selecciondo conceptos prioritarios de HCE: problemas, procedimientos, alertas y medicamentos, consturyéndose subconjuntos de los valoresposibles, que son implementados en interfce o como referenica con mapeos a los términos locales, dependiendo de las funcionalidades de las aplicaciones actuaes. Por otra parte, las especificaciones de datos clínicos detallados, como los formularios, se represenan mediante arquetipos y se enlazan con SNOMED CT (AU)
SNOMED CT is a comprehensive and detailed clinical terminology, in Spanish, which can be used to represent clinically relevant information consistently. The Fuenlabrada University Hospital adopted SNOMED CT in their information systems; this paper describes the implementation process and results (AU)
Subject(s)
Current Procedural Terminology , Hospital Information Systems/standards , Medical Records/standards , Information Management/standardsABSTRACT
In 2001, the Research and Biotechnology Division (RBD) of St Luke's Medical Center, in collaboration with the Institute of Tropical Medicine of Nagasaki University in Japan, initiated a long-term study of Japanese encephalitis in the Philippines. Laboratory confirmation of acute cases of Japanese. encephalitis was done by IgM-capture ELISA, which detects anti-JEV immunoglobulin M in cerebrospinal fluid (CSF) samples. In the period 2002-2004, a total of 614 CSF samples were submitted to RBD, and of these, 11.7% were positive for anti-JEV IgM: 17 in 2002, 18 in 2003, 32 in 2004, and 5 in 2005. Positive cases came from patients aged 2-77 years. In the 72 positive cases where gender was identified, 44 were male and 28 female. Possible co-infections with dengue virus were also detected by separate testing for anti-dengue IgM by ELISA in 17 CSF samples positive for JE.
Subject(s)
Encephalitis, Japanese/diagnosis , Enzyme-Linked Immunosorbent Assay/methods , Immunoglobulin M/blood , Immunoglobulin M/cerebrospinal fluid , Adolescent , Adult , Child , Child, Preschool , Encephalitis, Japanese/epidemiology , Encephalitis, Japanese/immunology , Female , Humans , Infant , Male , Middle Aged , Philippines/epidemiologyABSTRACT
Uracil and tegafur (in a molar ratio of 4:1 [UFT]) has proven activity against breast cancer and is delivered in an easy-to-administer oral formulation. Orzel, which combines UFT with the oral biomodulator, calcium folinate, may provide even greater antitumor efficacy against breast cancer. Here, we describe the preliminary results of this phase II trial investigating the feasibility of 250 mg/m2/day of UFT plus 45 mg/day of oral calcium folinate administered to highly pretreated patients with advanced breast cancer. The results indicate a highly tolerable regimen and an overall response rate of 27.8% in a group of poor-prognosis patients. These findings warrant continued investigation.
